Cargando…
Pten Dose Dictates Cancer Progression in the Prostate
Complete inactivation of the PTEN tumor suppressor gene is extremely common in advanced cancer, including prostate cancer (CaP). However, one PTEN allele is already lost in the vast majority of CaPs at presentation. To determine the consequence of PTEN dose variations on cancer progression, we have...
Autores principales: | Trotman, Lloyd C, Niki, Masaru, Dotan, Zohar A, Koutcher, Jason A, Di Cristofano, Antonio, Xiao, Andrew, Khoo, Alan S, Roy-Burman, Pradip, Greenberg, Norman M, Dyke, Terry Van, Cordon-Cardo, Carlos, Pandolfi, Pier Paolo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270016/ https://www.ncbi.nlm.nih.gov/pubmed/14691534 http://dx.doi.org/10.1371/journal.pbio.0000059 |
Ejemplares similares
-
Role of Dok-1 and Dok-2 in Leukemia Suppression
por: Niki, Masaru, et al.
Publicado: (2004) -
The perfect PTEN – transcriptional regulation by PTEN dictates sarcoma identity
por: Langdon, Casey G., et al.
Publicado: (2021) -
PTEN action in leukemia dictated by the tissue microenvironment
por: Miething, Cornelius, et al.
Publicado: (2014) -
SENP1 regulates PTEN stability to dictate prostate cancer development
por: Bawa-Khalfe, Tasneem, et al.
Publicado: (2016) -
Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma
por: Puzio-Kuter, A M, et al.
Publicado: (2015)